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Abstract Carnitine octanoyltransferase (COT), an enzyme that
facilitates the transport of medium chain fatty acids through
peroxisomal membranes, is inhibited by malonyl-CoA. cDNAs
encoding full-length wild-type COT and one double mutant
variant from rat peroxisomal COT were expressed in Saccha-
romyces cerevisiae. Both expressed forms were expressed
similarly in quantitative terms and exhibited full enzyme activity.
The wild-type-expressed COT was inhibited by malonyl-CoA
like the liver enzyme. The activity of the enzyme encoded by the
double mutant H131A/H340A was completely insensitive to
malonyl-CoA in the range assayed (2^200 WM). These results
indicate that the two histidine residues, H131 and H340, are the
sites responsible for inhibition by malonyl-CoA. Another mutant
variant, H327A, abolishes the enzyme activity, from which it is
concluded that it plays an important role in catalysis.
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1. Introduction
Carnitine octanoyltransferase (COT) is a member of the
family of carnitine acyltransferases that transfer fatty acyl
groups from carnitine to CoA and vice versa and thus facil-
itate the transport of fatty acids through various organelles
for further metabolization. COT is present in subcellular or-
ganelles, like the endoplasmic reticulum and peroxisomes [1^
3]. This feature may be derived from the capacity of the gene
to produce two proteins through a process of trans-splicing
[4]. In peroxisomes, COT activity is inhibitable by malonyl-
CoA [5] in a way similar to the mitochondrial carnitine pal-
mitoyltransferase (CPT) I. In contrast, mitochondrial CPT II
is not inhibitable by malonyl-CoA.
Inhibition of carnitine acyltransferase activities by malonyl-
CoA is produced by two sites of malonyl-CoA interaction:
one involves the catalytic acyl-CoA binding domain, and the
other, which has a greater capacity for binding and regulation
by malonyl-CoA, behaves as an allosteric component [6^9].
The involvement of His residues in the inhibitory modulation
by malonyl-CoA has been suggested [10,11]. Recently, several
attempts have been made to identify the domains and the
histidine or histidines of CPT I that bind malonyl-CoA but
they remain to be clari¢ed [12,13].
In this study, a double mutant version and the wild-type of
the COT enzyme have been expressed in the budding yeast
Saccharomyces cerevisiae and several parameters, including
malonyl-CoA sensitivity, have been analyzed. This approach
led us to identify H131 and H340 as the residues involved in
the response to malonyl-CoA, since their mutation abolishes
malonyl-CoA inhibition.
2. Materials and methods
2.1. Expression of COT cDNA in S. cerevisiae
The rat liver clone V2AxCOT, provided by Dr. Chatterjee [14], was
used as a probe in the screening of a Vgt10 rat liver cDNA library 5P-
stretch from adult male Sprague^Dawley rats (Clontech). Clone
VgtCOT14 was subcloned into the EcoRI site of plasmid pBluescript
(pBS-COT) and sequenced. This fragment, which encompasses the
entire coding sequence for COT and includes nt 33^2670 of the pre-
viously reported sequence U26033 [15], was used for the expression
experiments. The coding region of COT was subcloned into the
S. cerevisiae expression plasmid pYES2 (Invitrogen) as follows. The
NH2-terminal end of the open reading frame (nt 52^509) was ampli-
¢ed by PCR using plasmid pBS-COT. The forward oligonucleotide 5P-
TCG ATA AGC TTA TAA AAT GGA AAA TCA ATT GGC TAA
G-3P includes an extra HindIII restriction site (underlined) for sub-
cloning into the expression vector and a consensus sequence (bold),
optimized for e⁄cient translation, upstream of the S. cerevisiae start
codon. Oligonucleotide 5P-GGT TCA TGT CTA GAG CAG-3P was
used for reverse priming (XbaI site underlined). The ampli¢cation
fragment was digested with HindIII-XbaI, cloned in pYES2 and se-
quenced to con¢rm the absence of mutations. The construct was di-
gested with XbaI and ligated with the fragment XbaI-XbaI (nt 510^
2009) to yield pYESCOTwt.
For expression in yeast cells, the wild-type strain YPH499 (MATa
ura3-52 leu2-D1 ade2-101 lys2-801 his3-D200 trp1-D63) was trans-
formed with di¡erent constructs [16], and maintained in complete
minimal medium lacking uracil (CM(3ura)) with 2% glucose as car-
bon source [17]. For COT expression, cells from late exponential
cultures were recovered and grown for 12 h in CM(3ura) with gal-
actose as carbon source. Cells were then recovered by centrifugation
at 2000Ug for 5 min at 4‡C, washed in 20 ml of ice-cold bu¡er A
(150 mM KCl, 5 mM Tris^HCl pH 7.2), centrifuged again, and re-
suspended in 1 ml of bu¡er B (bu¡er B is bu¡er A supplemented with
1 mM PMSF, 0.5 mM benzamidine, 10 ng/ml leupeptin, 100 ng/ml
pepstatin). 0.5 ml of cold, acid-washed glass beads was added to each
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sample and cells were disrupted by vigorous vortexing (four pulses of
1 min, samples were kept on ice for 1 min after each pulse). Homo-
genates were centrifuged at about 800Ug for 3 min at 4‡C, to remove
glass beads and cell debris. This crude extract was further centrifuged
at 15 000Ug for 10 min at 4‡C. Pellets and supernatants were imme-
diately frozen and stored at 320‡C.
2.2. Site-directed mutagenesis
Site-directed mutagenesis of histidines 131, 327 and 340 to alanine
was carried out by the megaprimer method using asymmetric PCR
[18] and plasmid pYESCOTwt. The following oligonucleotides were
used: H131A: 5P-GCA TAC TAC TGT GGG CCA ACT TGA ACT
ACT GGC-3P ; H327A: 5P-GGC TGT AGC TGT GAT GCT GCT
CCT TAT GAT GC-3P and H340A: 5P-GGA GCT TCT CAT CAA
CGT ACG CAG CAA TGT TCA CCA TAA-3P. The mutated nu-
cleotides are underlined. To obtain the megaprimer fragments, the
oligonucleotides were COT57for : 5P-TCG ATA AGC TTA TAA
ACA ATT GGC TAA G-3P ; COT520rev : 5P-TCA TGT CTA GAG
TAT TTC CAG ATT TAT G-3P ; COT734for : 5P-GCT GGA AAT
GAA CCT GTT GGG-3P and COT1221rev : 5P-GCT GCT TTG
AGG TGT TGG GC-3P. The mutated fragments were used to con-
struct the plasmids pYESCOTH327A and the double mutant
pYESCOTH131A=H340A. The appropriate substitutions, as well as the
absence of unwanted mutations, were con¢rmed by sequencing the
inserts with an Applied Biosystems 373 automated DNA sequencer.
2.3. Determination of carnitine acyltransferase activity
Carnitine acyltransferase activity was determined by the radiometric
method as described in [19] with minor modi¢cations. The substrates
were decanoyl-CoA and L-[methyl-3H]carnitine. Enzyme activity was
assayed for 4 min at 30‡C in a total volume of 200 Wl. The protein
sample, 40 Wl (V2 Wg), was pre-incubated for 1 min, and then 160 Wl
of the reaction mixture was added. The ¢nal concentrations were
105 mM Tris^HCl (pH 7.2), 2 mM KCN, 15 mM KCl, 4 mM MgCl2,
4 mM ATP, 250 WM reduced glutathione, 50 WM decanoyl-CoA,
400 WM L-[methyl-3H]carnitine (0.3 WCi) and 0.1% defatted bovine
albumin. Reactions were stopped by the addition of 200 Wl of HCl
1.2 N, and the product acyl-L-[methyl-3H]carnitine was extracted with
water-saturated n-butanol. Km values were estimated by analyzing the
data from three experiments performed in triplicate using the program
Enz¢t (Biosoft). When malonyl-CoA inhibition was assayed, increas-
ing concentrations of malonyl-CoA were included. All protein con-
centrations were determined using the Bio-Rad protein assay with
bovine albumin as standard.
Liver rat peroxisomes were isolated in a Nycodenz cushion as pre-
viously described [20]. The peroxisomes were dispersed in 250 mM
sucrose, 10 mM Tris^HCl pH 7.4 and 1 mM EDTA and stored at
320‡C.
2.4. Immunological techniques
A peptide (EKLLETEGRWKGSEKVR) (residues 344^360) of
COT was synthesized as described in [21]. The peptide showed low
identity to other carnitine transferases. Generation of anti-COT anti-
bodies was performed as described [4]. Q-Globulins from peptide 344^
360 were designated A344. Western blotting analysis was performed
as in [22]. S. cerevisiae protein extracts were treated with sample
bu¡er and subjected to 10% SDS^polyacrylamide gel electrophoresis.
Immunodetection was performed using antiserum A344 (1/100) and
the blots were developed with the ECL Western blotting system from
Amersham Pharmacia Biotech.
3. Results and discussion
3.1. Analysis of histidines potentially involved in the inhibition
of peroxisomal COT by malonyl-CoA
To determine which of the His residues of COT were po-
tentially responsible for the inhibitory action of malonyl-CoA,
we examined all the His residues common to seven carnitine
acyltransferases (Fig. 1). We postulated that histidines a, b
and c cannot be responsible for the binding to malonyl-CoA
because they are absent in peroxisomal COT (the ¢rst amino
acid of the COT begins at position 152 of mitochondrial L-
CPT I), provided that both carnitine transferases have con-
served the same malonyl-CoA-inhibitable sites. In addition,
histidines e, g, h, l and m, which are present in CPT I and
not conserved in peroxisomal COT, are not candidates for
malonyl-CoA inhibition in COT. Moreover, those His resi-
dues present at the same position in all carnitine transferases
(histidines f, i and k) cannot be responsible for malonyl-CoA
sensitivity because CPT II is insensitive to the inhibitor. Ac-
cording to this reasoning, only two residues, present in the
malonyl-CoA-inhibitable enzymes and absent in non-inhibit-
able carnitine transferases, were candidates for malonyl-CoA
inhibition: histidine d, corresponding to peroxisomal COT
H131, and histidine j, corresponding to peroxisomal COT
H340 from the rat. We then decided to mutate the two His
residues presumably involved in binding with malonyl-CoA.
Since it has been proposed that histidine i is the amino acid
residue responsible for binding and catalysis of its substrate
for CPT II [23,24], on the basis of analogy with CPT II we
also mutated H327 in COT, to test its role in catalysis.
Fig. 1. Alignment of conserved histidines in seven carnitine acyltransferases. Sequences were obtained from the GenBank sequence data bank:
human CPT II (accession number U09648), rat CPT II (J05470), human L-CPT I (L39211), rat L-CPT I (L07736), human M-CPT I (D64178),
rat M-CPT I (D43623) and rat COT (U26033) [15,29^34]. Alignment of sequences was obtained with the PILEUP and PRETTY programs
from Wisconsin Package Version 9.1, Genetics Computer Group (GCG), Madison, WI, USA. At the top, the distribution of the 13 conserved
histidines is shown. At the bottom, * indicates the conserved histidines in malonyl-CoA-inhibitable enzymes (CPT I and COT), O indicates the
histidine conserved in all carnitine transferases and presumably involved in the acyl-CoA binding [23,24].
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3.2. Expression of peroxisomal COT in S. cerevisiae and
kinetic analysis of the enzyme
The pYES plasmid containing the COT wild-type was ex-
pressed in S. cerevisiae and the yeast extracts were assayed for
COT activity. Only the pellet enriched in peroxisomes exhib-
ited malonyl-CoA sensitivity, as reported by others with rat
liver extracts [20,25]. Therefore, we used the membrane frac-
tion for further studies. In cells transformed with the empty
plasmid, COT activity was not detected. To rule out the pos-
sibility that the various transformed yeast cultures expressed
variable amounts of peroxisomal COT we performed an im-
munoblot analysis. As shown in Fig. 2 all transformed yeast
cells expressed a protein with the same molecular mass and in
roughly the same proportion per mg of total protein. Thus,
S. cerevisiae is a good model to study COT activity, as has
been found for other carnitine transferases expressed in yeast
[12,26^28].
S. cerevisiae cultures transformed with the expression plas-
mid pYESCOTH131A=H340A, containing the double mutant en-
zyme, hardly grew when the inductor galactose was the car-
bon source. It was necessary to add glucose ¢rst to promote
growth, and then galactose to induce the expression of the
mutated version of peroxisomal COT.
Yeast-expressed COT activity of the double mutant H131A/
H340A was 206 nmol/min/mg protein which was double the
value of the wild-type (97 nmol/min/mg protein). Mutant
H327A, in which the putative catalytic site had been mutated,
lost all enzyme activity. This fact strongly suggests that H327
belongs to the catalytic site, as has also been proposed for
CPT II. The speci¢c activities of pYESCOTwt and of the
double mutant are high enough to be determined with ease.
Rat liver peroxisomal COT was inhibited up to 69% by 200
mM malonyl-CoA, which is consistent with the result (65%)
of Ramsay et al. [5]. The malonyl-CoA inhibition of wild-type
yeast-expressed COT was also similar (59%). Therefore, the
residual activity, not inhibitable, is probably due to the in-
trinsic characteristics of the enzyme, rather than to the ex-
pression system used.
The wild-type and the double mutated version of COT ex-
hibit hyperbolic saturation kinetics in response to varying
concentrations of carnitine or decanoyl-CoA (Fig. 3). The
calculated apparent Km values for carnitine in wild-type
(172 WM) and the double mutant (106 WM) are similar to
rat liver peroxisomes (218 WM). However, the Km of the
two expressed forms for decanoyl-CoA (2.0 and 13.1 WM re-
spectively) were higher than for rat liver peroxisomes (0.2
WM). An increase in the apparent Km for decanoyl-CoA in
the yeast-expressed CPT I was also observed by Prip-Buus et
al. [27]. The expression of these proteins in a heterologous
system could explain these di¡erences.
3.3. Inhibitory action of malonyl-CoA on the wild-type and
mutants of peroxisomal COT expressed in S. cerevisiae
Fig. 4A shows the malonyl-CoA-dependent inhibition of
the yeast COT in which the cells had been transformed by
the plasmid pYESCOTwt. The inhibitory plots were per-
formed at three di¡erent concentrations (5, 50 and 200 WM)
of decanoyl-CoA, as substrate. The inhibitory pattern was
maximal at the lowest concentration of decanoyl-CoA, show-
ing a competitive e¡ect of the malonyl-CoA towards decano-
yl-CoA. Fig. 4B shows the inhibitory pattern of malonyl-CoA
on the S. cerevisiae-expressed double mutant H131A/H340A
of peroxisomal COT. This mutant was not inhibited by ma-
lonyl-CoA at any concentration in the range 2^200 WM, nor
at any decanoyl-CoA concentration, despite the fact that the
enzyme was fully active. It appears that the mutation H/A in
Fig. 2. Immunoblot analysis of recombinant COT variants in S. cere-
visiae. Samples were prepared and analyzed as described in Section
2. S. cerevisiae extracts (10 Wg) were separated by SDS^PAGE and
subjected to immunoblotting using speci¢c A344 antibodies for
COT. Lane 1, extract from S. cerevisiae transformed with the empty
plasmid; lane 2, COT wild-type; lane 3, mutant H131A/H340A;
lane 4, mutant H327A. The arrow indicates the migration position
and the molecular mass of rat liver COT.
Fig. 3. Dependence of carnitine and decanoyl-CoA of wild-type and
mutant COT variants. Yeast extracts of wild-type and the double
mutant COT variant were incubated at increasing concentrations of
carnitine (A) or decanoyl-CoA (B). When decanoyl-CoA concentra-
tion was modi¢ed, the L-carnitine concentration was ¢xed at 400
WM, and when carnitine was modi¢ed the decanoyl-CoA concentra-
tion was ¢xed at 50 WM. Data are the mean of three independent
experiments.
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the two putative sites of malonyl-CoA interaction fully abol-
ishes the inhibitory e¡ect, con¢rming the hypothesis that these
are the two COT inhibitory sites of malonyl-CoA. H340, due
to its proximity to the catalytic site, may be the site at which
malonyl-CoA competes which other CoA esters, as described
for other carnitine transferases [5,6,9].
Identi¢cation of the histidine residues responsible for the
inhibition of carnitine acyltransferases by malonyl-CoA is
an important step in elucidating the key to the control of
L-oxidation. These results open the way to study whether
speci¢c mutations in either carnitine transferase alter the me-
tabolism of fatty acids in several tissues and in the pancreatic
L-cell in particular, which may determine the development of
diabetes. Studies on this topic are in progress in our labora-
tory.
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Fig. 4. E¡ect of malonyl-CoA on the activity of the wild-type and
point mutants of COT. S. cerevisiae cells were transformed with the
cDNAs for the wild-type (A) and the H131A/H340A double mutant
(B). Extracts were incubated with several decanoyl-CoA concentra-
tions (5 WM, dashed line; 50 WM, solid line; 200 WM, dotted line)
and increasing concentrations of malonyl-CoA. Data are expressed
relative to control values in the absence of malonyl-CoA (100%), as
the mean of three independent measurements þ S.E.M.
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